Terms: = Liver cancer AND SDHC, CYBL, 6391, ENSG00000143252, SDH3, PGL3, QPS1, CYB560 AND Treatment
12 results:
1. sdhc-related deficiency of SDH complex activity promotes growth and metastasis of hepatocellular carcinoma via ROS/NFκB signaling.
Li J; Liang N; Long X; Zhao J; Yang J; Du X; Yang T; Yuan P; Huang X; Zhang J; He X; Xing J
Cancer Lett; 2019 Oct; 461():44-55. PubMed ID: 31278950
[TBL] [Abstract] [Full Text] [Related]
2. Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu AX; Kang YK; Yen CJ; Finn RS; Galle PR; Llovet JM; Assenat E; Brandi G; Pracht M; Lim HY; Rau KM; Motomura K; Ohno I; Merle P; Daniele B; Shin DB; Gerken G; Borg C; Hiriart JB; Okusaka T; Morimoto M; Hsu Y; Abada PB; Kudo M;
Lancet Oncol; 2019 Feb; 20(2):282-296. PubMed ID: 30665869
[TBL] [Abstract] [Full Text] [Related]
3. Polymorphisms in Genes of Tricarboxylic Acid Cycle Key Enzymes Are Associated with Early Recurrence of Hepatocellular Carcinoma.
Wan S; Wu Y; Zhou X; Chen Y; An J; Yu X; Zhang H; Yang H; Xing J
PLoS One; 2015; 10(4):e0124471. PubMed ID: 25894340
[TBL] [Abstract] [Full Text] [Related]
4. Genetic variants in genes of tricarboxylic acid cycle key enzymes predict postsurgical overall survival of patients with hepatocellular carcinoma.
Du X; Wan S; Chen Y; Qu P; Huang X; Yu X; Yang H; Zhang Y; Xing J
Ann Surg Oncol; 2014 Dec; 21(13):4300-7. PubMed ID: 25081338
[TBL] [Abstract] [Full Text] [Related]
5. In vivo treatment of HCV core-positive HepG2 cells with the transfer of recombinant caspase-3 using a 2'-5' OAS promoter.
Zi Y; Wang Y; Wiegmann PS; Luo J; Feng D
Mol Med Rep; 2012 Mar; 5(3):631-6. PubMed ID: 22159511
[TBL] [Abstract] [Full Text] [Related]
6. Reversal effect of Dioscin on multidrug resistance in human hepatoma HepG2/adriamycin cells.
Sun BT; Zheng LH; Bao YL; Yu CL; Wu Y; Meng XY; Li YX
Eur J Pharmacol; 2011 Mar; 654(2):129-34. PubMed ID: 21195709
[TBL] [Abstract] [Full Text] [Related]
7. [Enhanced thymidine kinase gene vector and its killing effect on nasopharyngeal carcinoma in vitro and in vivo].
Shen CX; Wen Z; Qian YH; Guan XF; Mu SF
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 May; 45(5):414-9. PubMed ID: 20654181
[TBL] [Abstract] [Full Text] [Related]
8. Targeted gene therapy of nasopharyngeal cancer in vitro and in vivo by enhanced thymidine kinase expression driven by human TERT promoter and CMV enhancer.
Shen CX; Wen Z; Qian YH; Mu SF; Guan XF
J Exp Clin Cancer Res; 2010 Jul; 29(1):94. PubMed ID: 20626878
[TBL] [Abstract] [Full Text] [Related]
9. A mutant of hepatitis B virus X protein (HBx Delta 127) enhances hepatoma cell migration via osteopontin involving 5-lipoxygenase.
Zhang X; Ye LH; Zhang XD
Acta Pharmacol Sin; 2010 May; 31(5):593-600. PubMed ID: 20364155
[TBL] [Abstract] [Full Text] [Related]
10. [Hypoxia induces heat shock protein HSP70-2 expression in a HIF-1 dependent manner].
Xia LM; Tian DA; Zhang Q; Yan W; Zhu Q; Luo M; Zhou ZZ; Tang Y; Zhang QL; Wang W
Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):207-12. PubMed ID: 19335985
[TBL] [Abstract] [Full Text] [Related]
11. 3-Methylcholanthrene elicits DNA adduct formation in the CYP1A1 promoter region and attenuates reporter gene expression in rat H4IIE cells.
Moorthy B; Muthiah K; Fazili IS; Kondraganti SR; Wang L; Couroucli XI; Jiang W
Biochem Biophys Res Commun; 2007 Mar; 354(4):1071-7. PubMed ID: 17276403
[TBL] [Abstract] [Full Text] [Related]
12. Ligand substitution of receptor targeted DNA complexes affects gene transfer into hepatoma cells.
Ziady AG; Ferkol T; Gerken T; Dawson DV; Perlmutter DH; Davis PB
Gene Ther; 1998 Dec; 5(12):1685-97. PubMed ID: 10023448
[TBL] [Abstract] [Full Text] [Related]
